We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adient (ADNT) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Read MoreHide Full Article
The upcoming report from Adient (ADNT - Free Report) is expected to reveal quarterly earnings of $0.56 per share, indicating an increase of 9.8% compared to the year-ago period. Analysts forecast revenues of $3.48 billion, representing a decrease of 6.6% year over year.
Over the last 30 days, there has been a downward revision of 7.6% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Adient metrics that are routinely monitored and predicted by Wall Street analysts.
The consensus among analysts is that 'Net Sales- Asia' will reach $715.33 million. The estimate suggests a change of -4.4% year over year.
Analysts' assessment points toward 'Net Sales- Americas' reaching $1.74 billion. The estimate indicates a year-over-year change of -5%.
The combined assessment of analysts suggests that 'Net Sales- EMEA' will likely reach $1.07 billion. The estimate indicates a year-over-year change of -9.2%.
It is projected by analysts that the 'Adjusted EBITDA- Americas' will reach $89.61 million. Compared to the present estimate, the company reported $100 million in the same quarter last year.
According to the collective judgment of analysts, 'Adjusted EBITDA- Asia' should come in at $123.70 million. Compared to the current estimate, the company reported $113 million in the same quarter of the previous year.
Analysts expect 'Adjusted EBITDA- EMEA' to come in at $27.91 million. Compared to the current estimate, the company reported $48 million in the same quarter of the previous year.
Adient shares have witnessed a change of -7.5% in the past month, in contrast to the Zacks S&P 500 composite's +3.2% move. With a Zacks Rank #3 (Hold), ADNT is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Adient (ADNT) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
The upcoming report from Adient (ADNT - Free Report) is expected to reveal quarterly earnings of $0.56 per share, indicating an increase of 9.8% compared to the year-ago period. Analysts forecast revenues of $3.48 billion, representing a decrease of 6.6% year over year.
Over the last 30 days, there has been a downward revision of 7.6% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.
Given this perspective, it's time to examine the average forecasts of specific Adient metrics that are routinely monitored and predicted by Wall Street analysts.
The consensus among analysts is that 'Net Sales- Asia' will reach $715.33 million. The estimate suggests a change of -4.4% year over year.
Analysts' assessment points toward 'Net Sales- Americas' reaching $1.74 billion. The estimate indicates a year-over-year change of -5%.
The combined assessment of analysts suggests that 'Net Sales- EMEA' will likely reach $1.07 billion. The estimate indicates a year-over-year change of -9.2%.
It is projected by analysts that the 'Adjusted EBITDA- Americas' will reach $89.61 million. Compared to the present estimate, the company reported $100 million in the same quarter last year.
According to the collective judgment of analysts, 'Adjusted EBITDA- Asia' should come in at $123.70 million. Compared to the current estimate, the company reported $113 million in the same quarter of the previous year.
Analysts expect 'Adjusted EBITDA- EMEA' to come in at $27.91 million. Compared to the current estimate, the company reported $48 million in the same quarter of the previous year.
View all Key Company Metrics for Adient here>>>
Adient shares have witnessed a change of -7.5% in the past month, in contrast to the Zacks S&P 500 composite's +3.2% move. With a Zacks Rank #3 (Hold), ADNT is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>